InBios International, Inc.
InBios develops and manufactures diagnostic kits for infectious diseases affecting global public health. Products are designed for superior performance and value and include the FDA EUA Zika IgM ELISA and FDA cleared kits for Chagas, West Nile, Dengue, Cutaneous and Visceral Leishmaniasis. Assays in the pipeline include diagnostic kits for Chikungunya, Scrub Typhus, Strongyloides, Melioidosis, and Filaria. The company also provides contract manufacturing and assay development services.